HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 405 participants.

Also called NCT01456000

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 405 participants (enrolled count) (from the registry)
Sponsor
  • CardioFocus Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01456000
Other papers using this trial's data
  • Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation Journal of the American College of Cardiology, 2015-09-22 DOI, PubMed 26383722

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01456000. Randomized; no masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2014-12 (actual). Results posted on 2016-09-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)
Acronym
HeartLight
Condition
Paroxysmal Atrial Fibrillation
Intervention (Device)
EAS-AC (HeartLight)
Intervention (Procedure)
Control Arm Ablation
Lead sponsor
CardioFocus (class: industry)

Record details

Record id
cardio:ct-nct01456000
Content hash
d5c7377017dcbe3eb4164e9a1d55ccb0377d1252c002218e0715a0e980f7f7a8